Applied Clinical Trials
Institutional overhead remains one of the more contentious areas in clinical grant management. There can be substantial variations in these overhead rates from institution to institution with often times little immediately evident reason for the differences. Institution overhead rates in the United Kingdom seem to reflect that same imprecision.
Institutional overhead remains one of the more contentious areas in clinical grant management. There can be substantial variations in these overhead rates from institution to institution with often times little immediately evident reason for the differences. Institution overhead rates in the United Kingdom seem to reflect that same imprecision.
Unlike virtually any other developed country, the United Kingdom has a single health care provider, the National Health Service (NHS) in England and Wales, with comparable organizations in the other parts of the country. Yet overhead rates vary among the institutions conducting clinical research for commercial organizations.
Each year TTC reports on the relative costs of clinical grants around the world, drawing upon data in the GrantPlan database. Subscribers to this database conduct over 76% of all the commercial clinical trials. According to the data in GrantPlan, average institutional overhead rates in the United Kingdom have averaged around 25% percent over the last five years, an average figure substantially higher than the average institutional overhead rate, 17%, for the other countries in the European Union. Equally noteworthy is the range in institutional overheads across the NHS.
United Kingdom Institutional Overhead Quartiles
The median (and mean) overhead is 25%, with the lowest quartile at 20%. The highest quartile institutions haw overheads beginning at 30%. It appears that the institutions with the highest overheads though are the most willing to negotiate the actual overhead rate paid by the commercial organizations conducting research at that site. These highest quartile hospitals report an official overhead 10 points higher than actually accepted in the final clinical grant.—TTC (for more information, please contact help@ttc-llc.com).
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.